Chemical inhibitors of the protein 1700011L22Rik function by disrupting various signaling pathways within the cell, leading to a decrease in its activity. Wortmannin and LY294002 are specific inhibitors of phosphoinositide 3-kinases (PI3K), a family of enzymes involved in cellular functions such as growth, proliferation, differentiation, motility, and survival. By inhibiting PI3K, these chemicals prevent the activation of AKT, a serine/threonine-specific protein kinase that plays a key role in multiple cellular processes. The inhibition of AKT by Wortmannin and LY294002, as well as by Triciribine, a direct AKT inhibitor, results in a reduced phosphorylation of downstream targets, which includes the functional inhibition of 1700011L22Rik. ZSTK474, another PI3K inhibitor, similarly disrupts the PI3K/AKT signaling pathway, attenuating the activity of 1700011L22Rik.
Parallel to PI3K/AKT pathway inhibitors, the chemical rapamycin specifically inhibits mTOR (mammalian target of rapamycin), which is also involved in the PI3K/AKT/mTOR pathway. The mTOR signaling pathway plays a crucial role in cellular growth and metabolism, and its inhibition by rapamycin, as well as by PP242, a selective mTOR kinase inhibitor, and Torin 1, which targets both mTORC1 and mTORC2 complexes, leads to a decrease in activity of proteins regulated by this pathway, including 1700011L22Rik. Inhibition of other signaling pathways that can affect the function of 1700011L22Rik includes the use of PD98059 and U0126, which are selective inhibitors of MEK1/2 and therefore prevent the activation of ERK1/2 in the MAPK/ERK pathway. SB203580, which specifically inhibits p38 MAP kinase, and SP600125, an inhibitor of JNK, both from the MAPK family, also contribute to the inhibition of 1700011L22Rik by interfering with stress response pathways and other MAPK-regulated processes. PF-04691502 rounds out the list of inhibitors by simultaneously targeting both PI3K and mTOR, leading to a broad inhibition of the signaling required for the proper function of 1700011L22Rik.
SEE ALSO...
Items 11 to 11 of 11 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
ZSTK 474 | 475110-96-4 | sc-475495 | 5 mg | $75.00 | ||
ZSTK474 is a potent and selective PI3K inhibitor. By inhibiting PI3K, it disrupts the PI3K/AKT signaling pathway, which can lead to the inhibition of proteins regulated by this pathway, including potentially 1700011L22Rik. |